Details for 2018173179
Up to date per 01.04.2026
Actions
Details for 2018173179
Granted/Registered
European Patent
12.12.2018 A
06.01.2021 B1
10.06.2011
US
201161495884 P
26.07.2011
US
201161511901 P
15.08.2011
US
201161523790 P
A61K 38/36 20060101AFI20200403BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku, Osaka- shi OsakaJP
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
SCHEIFLINGER, FriedrichMichelbeürngasse 4/17 1090 WienAT
TURECEK, Peter, Dr.Weidling Hauptstrasse 59g 3400 KlosterneuburgAT
EWENSTEIN, Bruce15 Claflin Path Brookline, MA Massachusetts 02445-4401US
WONG, Wing Yen101 Lombard St No. 405W San Francisco, CA 94111US
SUITER, Tobias M.Rennweg 1b 35083 WetterDE
Information about Fees